Sequentially updating the likelihood of success of a Phase 3 pivotal time-to-event trial based on interim analyses or external information

  • Kaspar Rufibach, Paul Jordan, Markus Abt
  • Journal of Biopharmaceutical Statistics, November 2014, Taylor & Francis
  • DOI: 10.1080/10543406.2014.972508

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.1080/10543406.2014.972508